Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

10.15

-0.26 (-2.45%)

At close: Feb 17, 2026, 4:00 PM EST

10.11

-0.04 (-0.34%)

After-hours: Feb 17, 2026, 4:37 PM EST

Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 17, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,301	368	86	116	20	44
Market Cap Growth	273.26%	330.28%	-26.01%	472.04%	-54.55%	-33.49%
Enterprise Value	1,113	304	-2	1	6	5
Last Close Price	10.40	4.12	1.34	1.93	0.78	2.42
PB Ratio	7.03	3.70	1.04	1.08	1.18	1.63
P/TBV Ratio	6.88	3.70	1.04	1.08	1.18	1.63
Debt / Equity Ratio	0.00	0.01	0.02	0.09	0.86	0.52
Net Debt / Equity Ratio	-1.02	-1.07	-0.99	-1.04	-1.29	-1.13
Net Debt / EBITDA Ratio	3.79	2.08	2.42	3.73	0.68	0.95
Net Debt / FCF Ratio	4.41	2.78	2.56	3.93	0.76	1.06
Quick Ratio	21.69	10.29	14.33	8.99	2.90	8.10
Current Ratio	21.93	10.41	15.03	9.15	2.98	8.33
Return on Equity (ROE)	-36.87%	-52.59%	-30.59%	-46.82%	-153.03%	-80.07%
Return on Assets (ROA)	-23.93%	-32.15%	-19.96%	-23.15%	-47.42%	-37.91%
Return on Capital Employed (ROCE)	-27.00%	-51.30%	-40.60%	-27.30%	-126.10%	-78.10%
Earnings Yield	-3.51%	-13.01%	-33.97%	-25.21%	-167.88%	-73.64%
FCF Yield	-3.37%	-10.40%	-37.22%	-24.50%	-143.18%	-65.27%
Buyback Yield / Dilution	-24.43%	-2.97%	-53.44%	-182.56%	-26.48%	-53.88%

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q